Alzheimers

Three reasons why open source is working for Alzheimer's research

When the open source way starts finding its way to the likes of the pharmaceutical industry, it turns a few heads. A combination of free access and open data has started changing the medical research model, beginning with drug companies collaborating on research for Alzheimer's disease.

Dana Blankenhorn from ZDNet was dead on when he said » Read more

1 Comment

Drug companies to collaborate on Alzheimer's disease

The rising cost of development and research is making drug companies turn to each other for help. Rival companies that include Pfizer, AstraZeneca, and Roche plan on sharing clinical data in a standard format. But this isn't the first time we've seen pharmaceutical companies start to share data.

» Read more

0 Comments